3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma
Clinical trial NCT01183429 · COMPLETED
Trial details
- NCT number
- NCT01183429
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-12
- Primary completion
- 2018-09-13
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.